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Introduction
Titanium (Ti) is a biocompatible highly reactive metal with a stable 
surface oxide layer that permits the deposition of cellular components 
aiding successful integration of endosseous implants [1]. Modifying the 
surface properties of an implant can enhance osseointegration in the 
early stages of healing [2]. The clinically beneficial effect of a modified 
Ti implant surface (sand blasted acid-etched micro-rough hydrophobic 
surface (SLA)) on osseointegration has been widely demonstrated with 
evidence showing a significant promotion in early healing parameters 
such as peri-implant new bone formation and bone-implant contact 
percentages, compared with relatively smooth surfaces [2]. These 
observations were further supported by in vitro findings demonstrating 
distinct differences in the activity of committed osteoblastic cells on 
rough compared to smooth Ti implant surfaces [3-5]. Interestingly, 
the quantitative parameters to assess osseointegration have been 
shown to be further promoted by modifying surface free energy of 
the hydrophobic SLA to render it hydrophilic [6,7]. This modified 
(modSLA) surface seems to have an enhanced effect that significantly 
reduces the healing period compared to SLA. This was demonstrated 
by higher clinical implant attachment scores [8] as well as significantly 
higher neo peri implant bone formation and bone-implant contact, 
as early as two weeks post implantation [9,10]. Clinical examinations 
have also demonstrated modSLA to be capable of retaining bone debris 
[11] that may contribute to an earlier transcriptional up-regulation of 
important osteogenic markers in vivo compared to the hydrophobic 
SLA substrate, as early as 2 days post implantation in human subjects 
[12-14]. 
It has been suggested that the mechanism underlying the improved 
osseointegration of modified Ti surfaces is an enhancement in cellular 
differentiation and function instigated in response to physical cues 
from micro-rough topographies [15-17]. This hypothesis is supported 
by studies examining the effects of modified Ti surfaces on multipotent 
human mesenchymal stromal cells (MSCs). MSCs have been implicated 
in tissue repair and regeneration in vivo [18] and can differentiate into 
at least three mesenchymal phenotypes (chondrogenic, adipogenic 
and osteogenic), suiting them for in vitro modelling of tissue repair 
and healing. Further it has been shown that MSCs exhibit different 
levels of calcium mineralisation in vitro dependant on the Ti substrate 
used [15,17], seemingly under the influence of selectively stimulated 
molecular pathways [19,20].
AXL is a cell surface receptor expressed on MSCs [21] that 
dimerises in the presence of its natural ligand GAS6 to initiate a 
range of cellular functions, including survival, inflammation and 
differentiation [22]. Previously microarray analyses have shown that 
Abstract
Titanium (Ti) implants with micro-rough topography and high surface free energy promote osseointegration, which 
in vitro analyses suggest is due to a novel enhancement in cellular osteogenic differentiation and function. The AXL 
receptor tyrosine kinase (AXL) is expressed on mesenchymal stromal cells (MSCs) and is implicated with its ligand, 
Growth arrest-specific 6 (GAS6), in the negative regulation of osteogenic differentiation, and may be modulated in the 
enhanced osteogenic differentiation of MSCs on modified Ti surfaces. This hypothesis was tested by culturing human 
MSCs on tissue culture plastic (TCP), polished (P), micro-rough-hydrophobic (SLA) and micro-rough hydrophilic 
(modSLA) Ti surfaces for seven days. Total RNA and protein levels of AXL and GAS6 were examined by real time 
PCR and ELISA, respectively. The effects of deregulating the signalling pathway in hMSCs with either receptor agonist 
or antagonist were investigated by analysing calcium mineralisation and soluble osteoblastic marker synthesis. The 
MSCs were found to significantly down-regulate AXL and GAS6 earlier on rough surfaces compared to smooth 
over seven days. Addition of the receptor agonist caused a relative decrease in calcium mineralisation that was 
most marked for TCP compared to any Ti surface. The antagonist did not affect mineralisation but caused a relative 
increase in osteoblastic soluble protein levels on rough surfaces only. Gene expression data showed an up-regulation 
of RUNX2 and beta-catenin with the receptor antagonist. These findings suggest that a down-regulation of AXL 
correlates with increased cellular mineralisation on the modified surfaces and that it might be a putative biomarker for 
assessing the clinical efficacy of endosseous implants.
Citation: Khan MR, Donos N, Salih V, Brett PM (2014) Receptor Kinase AXL is Modulated in the Osteogenic Differentiation of Human Mesenchymal 
Stromal Cells on Modified Titanium Implant Surfaces. J Stem Cell Res Ther 4: 233. doi:10.4172/2157-7633.1000233
Page 2 of 10
Volume 4 • Issue 9 • 1000233
J Stem Cell Res Ther
ISSN: 2157-7633 JSCRT, an open access journal 
AXL is transcriptionally up-regulated in human alveolar bone cells very 
soon after contact with rough Ti surfaces [5]. AXL was simultaneously 
shown to undergo down-regulation prior to osteogenic mineralisation 
in bovine MSC like cells called pericytes in vitro [23,24] as well as in the 
progression of chondrogenenic differentiation of human MSCs [25]. 
Restoration of AXL/GAS6 signalling has also been associated with 
the inhibition of ectopic endothelial cell calcification in vivo through 
statins [26]. The function of the Twist transcription factors, which 
are downstream effectors of this pathway, strongly suggests that the 
pathway is a potent negative regulator of osteogenic differentiation 
[27]. These characteristics of AXL suggest that it might be a suitable 
biomarker for the evaluation of the effectiveness of novel implant 
surface designs and materials for osseointegration.
The present study hypothesised that AXL and GAS6 are differentially 
modulated resulting in the enhanced osteogenic responses of MSCs to 
modified Ti implant surfaces in vitro. This hypothesis was examined in 
human MSCs cultured on tissue culture plastic (TCP), polished Ti (P), 
rough-hydrophobic (SLA) and rough-hydrophilic (modSLA) Ti discs 
in osteogenic medium (OM) alone or OM supplemented with either 
agonist or antagonist of the AXL receptor. The effects of deregulating 
receptor signalling on MSCs were assessed by quantifying extracellular 
matrix calcium and collagen content, soluble Osteoprotegrin (OPG) 
and Growth Differentiation Factor type 15 (GDF-15) levels in culture 
supernatant. 
Materials and Methods
Modified Ti surfaces
The Ti discs were supplied by Institut Straumann AG (Walderberg, 
Switzerland). Three modified Ti implant surfaces were investigated in 
this study: a polished (P), rough-hydrophobic sand blasted acid etched 
(SLA) and rough-hydrophilic (modSLA) Ti surfaces. The implant 
surfaces were manufactured discs of 1.8 cm2 surface area (diameter=15 
mm) designed for use in a ~1.96 cm2 well of a 24-well tissue culture 
plate. A detailed overview of the methods of processing these surface 
modifications along with their physical and chemical characterization 
is outlined by Rupp et al. [6]. In brief, the Ti discs were punched out 
from sheets of commercially pure Ti (of grade III). The crude discs were 
polished to a mirror on one side with SiO2 grinding paper with a grit 
diameter of 15 - 600 μm. These discs were further treated with diamond 
paste in oil and finally with a SiO 2 suspension to obtain a fine mirror-
like surface. The polished Ti surface has been analyzed by scanning 
electron microscopy to have a Ra value, representing the average vertical 
distance between the lowest and highest points within topography, of 
0.6 μm. The SLA discs were prepared by blasting a polished surfaces 
with large alumina particles, average in a diameter by 250 μm, and then 
acid-etching in a hot solution of hydrochloric (HCl) and sulphuric 
(H2SO4) acids. Following acid etching, the discs would be washed 
several times in de-ionised water and air dried. The modSLA surface 
was produced on polished discs with a method similar to that used for 
the SLA surface, with the exception of the final rinse being conducted 
under nitrogen protection. By minimizing chances of contamination 
by atmospheric oxygen and organic chemical moieties, the modSLA 
has a higher surface energy. The modified discs were supplied sealed 
in glass tubes, immersed in isotonic NaCl at pH 4-6. The arithmetic 
mean Ra value of the SLA and modSLA titanium surfaces is reported to 
be similar at 3.22+0.88 μm [6]. The hydrophilicity due to high surface 
energy of the modSLA surface has been evaluated with advancing 
contact angle measurements to be 91.31, 139.88 and 0 degrees for 
the polished, SLA and modSLA surfaces, respectively [6]. The P and 
SLA discs required passivation prior to use by immersing discs in 10% 
(v/v) nitric acid in de-ionised water, followed by air-drying and then 
sterilisation with UV radiation. The modSLA discs were supplied in 
sealed vacuum glass vials containing sterile saline and were handled 
submerged in liquid until the point of cell seeding. 
Cell culture
The human bone marrow derived mesenchymal stromal cells 
(hMSCs) were from three healthy unrelated donors (Caucasian; Male; 
20-30 years old) and were obtained from the Institute for Regenerative 
Medicine, Texas A&M Health Science Centre, College of Medicine 
(USA). The cells were isolated from bone marrow aspirates by density 
centrifugation and tissue culture plastic adherence. The hMSCs had been 
pre-characterised for colony forming units, osteogenic, chondrogenic 
and adipogenic differentiation, and expression of a repertoire of 
stromal cell surface markers. The cells were cultured as described in 
previously [28,29]. In brief, cells were expanded at a low density (100 
cells per cm2) in growth medium (GM) consisting of Minimal Essential 
Medium alpha (Gibco, UK) supplemented with 10% (v/v) lot-selected 
fetal calf serum (Gibco), 1% (v/v) antibiotics (Penicillin/Streptomycin; 
PAA Laboratories) and 0.1% (v/v) fungicide (Amphotericin B; 
Gibco). Cell expansion was carried out in 150 cm2 tissue culture (TC) 
treated flasks (Nunc) at 37ºC and 5% CO2 with twice weekly medium 
changes. Cultures attaining 80% confluence were detached with a 
solution of 0.05%/0.002% Trypsin/EDTA in Ca+2/Mg+2-free PBS 
(PAA Laboratories). Experiments were performed using cells that had 
undergone a maximum of three passages. Osteogenic differentiation 
was induced by culturing cells in osteogenic medium (OM) comprising 
Dulbecco’s Modified Eagle’s Medium low glucose supplemented with 
10% (v/v) lot-selected fetal calf serum (Gibco), 1% (v/v) antibiotics and 
0.1% (v/v) fungicide (Gibco), 10 nM dexamethasone (water soluble; 
Sigma-Aldrich), 10 mM β-glycerolphosphate (Fischer Scientific) 
and 50 μM ascrobate-2-phosphate (Fluka). Recombinant proteins 
were applied to deregulate AXL receptor signalling as previously 
described [23]. The agonist was recombinant human Gas6 (885-GS; 
R&D Systems) that was supplemented in OM at a final concentration 
of 0.25 µg/ml. The antagonist (MAb) consisted of three molecules; 
recombinant human AXL extracellular domain (AXL-ECD) (154-AL-
x; R&D Systems), and blockade monoclonal antibodies against receptor 
(AF154; R&D Systems) and ligand (AB885; R&D Systems). The final 
concentrations of these components was as follows; AXL-ECD 4 µg/
ml; anti-AXL blockade monoclonal antibodies 2.5 µg/ml; and anti-
GAS6 monoclonal antibodies 10 µg/ml. Cell proliferation was assessed 
with the AlamarBlue (Abdserotec) assay as described in [17]. Briefly, 
viable cells were incubated with 10% (v/v) AlamarBlue dye in medium 
for 4 h. A 100 µl aliquot of conditioned medium was transferred to an 
opaque 96-well microtitre plate and fluorescence intensity determined 
at excitation 530 nm and emission 590 nm. 
Gene expression analysis of AXL and GAS6 
Transcriptional changes in AXL, GAS6 and their relevant 
downstream effector TWIST1 were examined at 1, 3 and 7 days post 
seeding by real time polymerase chain reaction (RTPCR) using the delta 
Ct method. For this analysis, hMSCs (N=3) were seeded at a density of 
2.5x104 cells per surface in 1 ml medium in triplicate in 24 well plates 
(Nunc). The surfaces tested were tissue culture plastic, P, SLA and 
modSLA Ti discs. The analysis was conducted with GM and OM as 
these media may variably affect the signalling pathway. Total RNA was 
extracted with the Qiagen RNeasy Mini kit (Qiagen) according to the 
manufacturer’s instructions. The integrity and quantity of extracted 
RNA was evaluated by spectrophotometery (λ260: λ280 nm; M200, 
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Tecan). A total of 400 ng of RNA per sample was converted to 100 
μl cDNA by first strand synthesis reactions using the High Capacity 
Reverse Transcription Kit (Applied Biosystems) according to the 
manufacturer’s instructions. RTPCR reactions were performed in a 
7300 Real Time PCR System (Applied Biosystems) in 25 μl reactions 
with 2.5 µl of cDNA per reaction (10 ng of RNA equivalent). Human 
specific Taqman probes for the three genes were used at 1.25 µl per 
reaction. The Taqman probes used were AXL (Hs01064444_m1), 
GAS6 (Hs01090305_m1) and TWIST1 (Hs00361186_m1) (all from 
AppliedBiosystems). The Ct values of markers were normalised to the 
GAPDH house keeping gene and calibrated to ΔCt values of cells in 
suspension (at time zero) to obtain relative fold values of expression. 
Protein examination of AXL and GAS6 
ELISA was used to quantify AXL and GAS6 proteins at 1, 3 and 7 d 
post seeding as it allowed a quantitative estimate as opposed to a semi-
quantitative output of a western blot. Three donors were examined 
separately in two different media conditions (GM and OM). Samples 
were formed in 24 well plates by seeding hMSCs at a density of 2.5x104 
cells per surface in 1 ml of medium on TCP, P, SLA and modSLA; in 
6 replicates (n=6) per time point per condition per donor, for later 
pooling as the pooling of multiple replicates was required to yield 
minimally detectable levels of protein for the sensitivity of the ELISA 
kits. 
Total and tyrosine phosphorylated AXL were quantified in pooled 
cellular homogenates using two kits (R&D Systems; DYC1643-2; 
DYC2228-2, respectively). For this cell monolayers were washed twice 
with PBS and lysed in situ by adding 100 µl of lysis buffer per sample 
well for 15 minutes on ice. The lysis buffer comprised 20 mM Tris 
(pH 8.0), 137 mM NaCl, 10% glycerol, 2 mM EDTA, 1 mM activated 
sodium orthovanadate, 10 µg/ml Aprotinin, and 10 µg/ml Leupeptin 
(all Sigma). The homogenates of sample replicates were then pooled 
and stored at -80ºC. Samples were assayed by centrifuging at 2000xg 
for 5 minutes and testing 100 µl supernatant per each ELSIA kit as per 
manufacturer’s instructions. 
The soluble GAS6 molecule was quantified with ELISA (R&D 
Systems; Dy88g). For this purpose, culture medium was collected and 
pooled (n=6) following replacement every day for seven days. After each 
medium collection, cell numbers were estimated with the AlamarBlue 
assay as described above and medium re-replaced for the following 
24 hour period. The pools of medium were frozen at -80ºC for later 
lyophilisation in a freeze dryer. The resulting mass was reconstituted in 
0.5 ml deionised water. The total amounts of AXL and GAS6 measured 
were normalised to estimated cell numbers. 
Effects of AXL pathway de-regulation on extracellular matrix 
calcium mineralisation
The effect of AXL/GAS6 signalling on osteogenic mineralisation 
was assessedby two methods; a semi-quantitative assay using Alizarin 
Red S (Sigma) staining; and a quantitative determination of extra 
cellular matrix calcium using the QuantiChrom calcium assay kit 
(DICA 500, Universal Biologicals). For the Alizarin red measurements 
cells were seeded at a density of 6x105 per 9.6 cm2 in a 6-well plate 
and cultured for 14 days under the following four conditions: growth 
medium (GM), osteogenic medium (OM), OM with antagonist and 
OM with agonist. Staining was conducted by initially fixing monolayer 
in 4% paraformaldehyde in PBS for 30 minutes at room temperature 
followed by two washes in PBS. To each well, 3 ml of 2% Alizarin stain 
in deionised water (pH 4.1) were added for 20 min and then washed 
with copious amounts of water. Samples were air dried and scanned 
on a flatbed scanner (Epsom photo, 4200). For the QuantiChrom 
assays hMSCs were cultured in 24 well plates on TCP, P, SLA and 
modSLA surfaces in OM only, and OM with agonist or antagonist 
in triplicate at a density of 2.5x104 cells per well. After seven days, 
AlamarBlue assays were conducted to estimate cell numbers followed 
by homogenisation of monolayer in 1 M HCl in deionised water for 10 
min at room temperature. A 5 µl volume of each sample was assayed as 
manufacturer’s instructions. The calcium quantities determined were 
normalized to total cell numbers estimated by the AlamarBlue assays. 
Effects of AXL pathway de-regulation on extracellular matrix 
collagen deposition
The formation of ECM collagen was measured after 7 d in culture 
with the Sircol Collagen assay kit (Biocolor, UK). The cells were seeded 
at a density of 2.5x104 cells per surface in 24-well plates in triplicate 
on TCP, P, SLA and modSLA in OM alone, and OM with agonist 
or antagonist. Samples were homogenised with 400 µl of cold 0.5 M 
acetic acid (Sigma) supplemented with 100 µg/ml porcine pepsin 
(Sigma-Aldrich) for 10 minutes at room temperature. Homogenates 
from three replicate wells were pooled and concentrated overnight 
with 200 µl Isolation and concentration reagent at near 0ºC. The 
pooling of samples was required due to the small amounts of collagen 
formed by cells in individual wells. Concentrated pooled replicates of 
a sample were centrifuged to pellet the collagen and the albumin rich 
supernatant was discarded. Collagen pellets were stained with Sirius 
red in picric acid for 30 min and later washed in acid-salt solution to 
remove excess unbound dye. Bound stain was eluted with 250 µl of an 
alkali solution. The absorbance of 200 µl of each sample was measured 
at 555 nm in a clear micro titer plate. Total quantities were determined 
by interpolating absorbance values from a 6 point standard curve. 
Effects of AXL pathway de-regulation on osteoblastic soluble 
marker levels
ELISA assays were used to quantify the levels of soluble osteoblastic 
markers osteoprotegrin (OPG) and growth differentiation factor 15 
(GDF-15) in culture supernatant. The cells were seeded at 2.5x104 cells 
per surface on TCP, P, SLA and modSLA in OM, OM with agonist or 
OM with antagonist. Culture supernatant was collected and replaced 
every 24 hours for 7 d. Samples were diluted 1:10 in deionised water 
to assay for OPG (R&D Systems; DY805) and GDF-15 (R&D Systems; 
DY957), according to the manufacturer’s instructions. Quantities were 
normalised to total cell numbers estimated with the AlamarBlue assay. 
Statistical analysis
Statistical analysis of data was undertaken with the Graphpad 
Prism v5.02 software. Experiments were conducted with three donors 
(N=3) with number of replicates indicated by (n). Data was analysed 
with a 2-way ANOVA followed by Bonferroni post-test. 
Results
Gene expression of AXL, GAS6 and TWIST1 on different 
surfaces 
All genes displayed very low fold expression in hMSCs (Figure 1). 
AXL was expressed at similar levels in all conditions at 1 d and displayed 
a small increase in transcription at 3 d post seeding, returning to base 
line levels by 7 d. GAS6 did not display noticeable transcriptional 
changes though it was expressed relatively higher in OM than GM. 
TWIST1 displayed varied results with its expression higher in GM 
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than OM. However at 3 d its expression had significantly increased on 
the rough surfaces compared to smooth. Furthermore, OM caused a 
decline in its transcription on all surfaces. 
Protein changes in AXL and GAS6 on different surfaces 
The quantities of total and tyrosine phosphorylated AXL, and 
soluble ligand GAS6 were quantified in pools of six replicates of human 
MSCs cultured on TCP, P, SLA and modSLA in osteogenic medium 
(Figure 2). Cellular AXL was initially detected at near similar levels on 
all surfaces. TCP cultured cells displayed a highly significant (p<0.001) 
increase in AXL total protein and tyrosine phosphorylation compared 
to Ti. Comparisons between the Ti surfaces showed the rough 
significantly decreased receptor quantities compared to P at 3 d and 
7 d, which was corroborated by the relatively lower levels of receptor 
Figure 1: Gene expression assayed in hMSCs were cultured in growth (GM) or osteogenic (OM) media on TCP, P, SLA and modSLA Ti surfaces at 1, 3 and 7 days 
post seeding showed small fold expression of all genes. AXL (a,b) and GAS6 (c,d) did not display any surface specific changes in expression, although the ligand was 
transcribed relatively higher in OM than GM. TWIST1 (e,f) displayed surface specific differences in expression, being significantly up-regulated by rough compared 
to smooth at 3 d (p<0.05) in GM. The gene was expressed at relatively higher levels on TCP than Ti at 3 d in OM. Bars represent mean + SEM; N=donors=3, 
n=replicates=3. a= p<0.05, TCP vs. Ti surface.
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phosphotyrosine estimates at 1 d and 7 d on the rough vs. smooth 
(p<0.05). The secreted cytokine Gas6 was present at similar levels on 
all surfaces at 1 d. Its levels increased on TCP, P and SLA surfaces at 
3 d, while decreasing significantly on the modSLA. Quantities of the 
cytokine decreased on all surfaces by 7 d, but were observably lower on 
the modSLA compared to all other surfaces.
Effects of AXL pathway deregulation on extracellular calcium 
mineralisation
An Alizarin Red S stained digital scan of hMSCs cultured in 6 well 
plates in either growth medium (GM), osteogenic medium (OM), OM 
with antagonist, OM with agonist or with both is presented in Figure 
3a. The GM and OM cultured control samples displayed negative and 
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positive stained monolayers, respectively. The OM with antagonist 
stained positive for Alizarin but stain intensity was visibly lower than 
the control OM. The OM with agonist cultured cells displayed a stark 
decline in stain compared to control and OM with antagonist while their 
combination yielded an intermediate stain. In the second analysis, the 
amount of calcium per cell was determined with a colorimetric assay. 
The result of this experiment is shown in Figure 3b. It demonstrates 
that human MSCs mineralise along the previously reported trend 
for the control condition, OM only, by depositing higher mineral on 
modSLA than SLA than P than TCP. The addition of receptor agonist 
decreased the quantity of calcium per sample relative to its control 
though the trend of higher mineralisation on modSLA>SLA>P>TCP 
was still preserved. This down-regulation in mineralisation was strongly 
evident in the TCP sample as that substrate fails to induce osteogenic 
mineralisation at a level comparable with the Ti surfaces. 
Effects of AXL pathway deregulation on matrix collagen 
formation
The ECM collagen formed by samples was estimated at 7 days 
post seeding. The results of this analysis are illustrated in Figure 4a. It 
indicates collagen synthesis was similar between all surfaces and not 
affected by AXL deregulation. Previously reported ratios of calcium to 
collagen for control medium [17] were observed again. The antagonist 
was found to have a small yet significant increase in calcium per 
collagen on the modSLA surface only. The decline in mineral content 
upon TCP in the presence of agonist was evident by the observation of 
the lower calcium per collagen ratio (Figure 4b). 
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Effects of AXL pathway deregulation on soluble osteoblastic 
marker levels 
The osteoblast associated cytokines OPG and GDF-15 were 
quantified in culture supernatants of hMSCs on the different surfaces 
in control, agonist or antagonist supplemented media (Figure 5). The 
OPG was expressed at a similar level by all samples at this time in control 
medium OM only. Both conditions inducing receptor deregulation 
had modulated an increase in OPG soluble levels. This increase was 
statistically significant for antagonist compared to osteogenic medium 
only control cultured cells of every surface. Statistically highest level of 
soluble OPG was detected in cells cultured on the rough surfaces than 
all samples. A similar trend was observed for GDF-15. Its secretion was 
relatively higher on the rough compared to smooth control in medium. 
Receptor agonist did not affect GDF-15 soluble levels compared 
to controls. However, the antagonist relatively increased its levels 
compared to control medium. This increase was relatively pronounced 
in cells on the rough surfaces compared to smooth. 
Discussion
Previous studies have examined the cellular responses to the SLA 
and modSLA Ti implant surfaces in an attempt to understand the 
cellular and molecular events that underlie their different performance 
in vivo, however, more recently studies have assessed the possibilities 
offered for bone related tissue engineering. These studies have examined 
whether the modified Ti substrates influence sub-cellular processes that 
manifest in an enhancement of osteogenic differentiation and function. 
The present study evaluated if the tyrosine kinase receptor AXL and 
its ligand GAS6 were differentially modulated during osteogenesis in 
human MSCs cultured on the SLA and modSLA Ti surfaces. AXL has 
been previously shown to have osteo-inhibitory effects on the in vitro 
mineralisation of uncommitted pericytic cells [23] and the reduction 
in endothelial ectopic calcification in vivo from the re-constitution of 
signalling by statins [26]. It is suggested that AXL has an important 
role preceding osteogenenic induction, being down regulated with the 
initiation and progression of calcium mineralisation [24]. In this study, 
genetic and protein changes to AXL and GAS6 were examined in cells 
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cultured on four experimental surfaces, with a further evaluation of 
the effects of this pathway's deregulation on osteogenic differentiation 
with receptor agonist or antagonist molecules that could increase or 
decrease signalling, respectively.
It was shown that AXL and GAS6 were differentially expressed by 
cells in response to the different surfaces they were cultured on. This 
difference was far less obvious at the transcript level but stark at the 
protein level, with significant reductions in both total AXL and tyrosine 
phosphorylated AXL proteins on the rough surfaces compared to 
smooth in culture. Changes in transcription of the GAS6 gene were 
nominal over the time course; however, the soluble protein was detected 
at higher levels in osteogenic differentiation than control medium and, 
similar to the AXL protein, showed a comparative reduction on the 
modSLA and SLA rough surfaces compared to smooth over time in 
culture. These observations suggests that cells on the rough surfaces 
were undergoing an enhancement in osteogenic differentiation and 
therefore down-regulated the osteo-inhibitory activity of AXL in order 
to initiate the earlier deposition of extracellular matrix. Clinical in 
vivo studies utilising gene expression arrays have shown an earlier up-
regulation of key osteogenic markers in response to modified implant 
surfaces, adding weight to the hypothesis that modified surfaces may 
induce a de novo enhancement in osteogenic differentiation and 
activity [12-14]. This hypothesis is corroborated by the observation 
of the down-regulation of TWIST1 gene expression in osteogenic 
medium relative to control medium and was later found to be inversely 
proportional to the extent of cellular mineralisation achieved after 
seven days. 
The effects of deregulating AXL signaling in hMSCs demonstrated 
the importance of the pathway in osteogenic differentiation, as well as 
the significance of its differential modulation in cells on the different 
surfaces. The agonist induced a decrease in calcium mineralisation 
on all surfaces that was significant only in the case of TCP cultured 
cells, possibly due to the reduced level of differentiation and matrix 
mineralisation seen on this surface compared to rough. The significant 
increase in the levels of soluble osteogenic markers on the rough surfaces 
caused by down-regulating AXL signaling by the receptor antagonist 
suggests these osteoclastogenic inhibitors may partly underpin the 
significant rise in peri-implant bone accrual seen for modSLA and SLA 
implants in vivo [7,8]. Furthermore, the expression and reduction in 
activity in hMSCs with the progression of osteogenic differentiation, 
implicates AXL with the maintenance of hMSC stemness. 
Osteogenic differentiation is not a simple one-step process 
with a single path of initiation; rather it appears to be the net effect 
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of several separate cellular processes, each possibly being induced 
by a single event of commitment. The findings here and in previous 
studies show the importance of both the substrate and its topography 
on the osteogenic differentiation of uncommitted cells in vitro [15-
17,19]. Though the extent to which these observations truly replicate 
osteogenesis in vivo remains debatable, the fact that they are taking 
place on a material whose very basis of in vivo application is its ability 
to accrue bone matrix compared to the synthetic non-biological 
tissue culture plastic widely used in vitro cell biology, gives weight to 
the theory of de novo 'accelerated osteogenesis' proposed previously 
[15]. The important underlying molecular mechanisms governing 
the differential modulation of AXL are of high importance. Though 
the receptor is ubiquitously expressed in several uncommitted cell 
types, the dynamics of ligand GAS6 expression, promoter control 
and post translational activation, particularly in osteogenesis, are still 
poorly understood [22]. In addition, the present data set is insufficient 
to draw a discrete association between the pathway and a specific 
cellular response that may result in osteo-inhibition. Never the less, 
the correlation of its differential modulation with the onset and degree 
of mineralization strongly suggests a close association between the 
pathway and MSC commitment to an osteogenic lineage. 
One might also infer from the findings in this study that the use of 
titanium substrates will provide a better in vitro model for bone related 
drug discovery, since their behaviour in vivo is well studied, making 
correlation between in vivo an in vitro effects more relevant than that 
on TCP. Furthermore, as a putative marker for assessing bone implant 
surface design, understanding the dynamics of AXL signaling and its 
regulation may shed light on the mechanisms governing the different 
osteogenic responses observed on the Ti substrates and therefore aid in 
developing strategies to enhance titanium's applications in bone tissue 
engineering.
Conclusion
The receptor AXL and its ligand GAS6 are expressed at genetic 
and protein levels in human MSCs prior to differentiation. With the 
induction and progression of osteogenic differentiation, these signaling 
components are down-regulated in vitro with a clear correlation to the 
clinical efficacy of the Ti implant surfaces in vivo, suggesting AXL might 
be a surrogate marker for material/surface efficacy for the assessment 
of future implant surface design and development. 
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